Ego Pharmaceuticals Celebrates 30 Years of Success in the Middle East

A leading Australian dermatological skincare company is proudly celebrating two major milestones this year, with 70 years of operations globally and 30 years in the Middle East.

Ego Pharmaceuticals became the first Australian skincare company to venture into the Middle East, despite being relatively unknown at the time. Over three decades, Ego has solidified its presence in the region, which currently contributes to 50% of its total exports and 25% of its overall global business.

With a workforce of 110 professionals across 7 Middle Eastern countries, Ego Pharmaceuticals is moving to a new MEA support centre in central Dubai this September and expanding operations in Saudi Arabia later in the year.

Alan Oppenheim, Managing Director, said of the company’s journey:

“Ego’s entry into the Middle East was a significant leap for our small company. Looking back on the collective efforts of our teams in Australia and the Middle East over these three decades fills me with immense pride. Knowing that our products have played a role in improving the lives of those in the Middle East dealing with chronic skin conditions is truly gratifying. We are now a leading Australian company with sustainable operations in a vibrant and growing Middle East market.”

Ego Pharmaceuticals’ dedication to the Middle East has resulted in consistent growth. From its initial entry into the UAE in 1993, the company expanded its presence into Bahrain, Jordan, Saudi Arabia, Kuwait, Qatar, and Oman.

Ego’s thriving export success to the Middle East has led to significant investments in its Australian operations, based in Melbourne, including current projects to upgrade its manufacturing facility and the expansion of its global distribution centre. These initiatives are expected to increase production capacity by 100 per cent and create 90 new jobs.

Must Read

Improving the lives of PCOS sufferers

Polycystic ovarian syndrome (PCOS) is a common hormonal condition that affects one in 10 women of reproductive age1, and up to 13 per cent...